📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Insecticides (India) Reports 8% Q3 Revenue Growth; 9M PAT Stands at ₹128 Crores
Insecticides (India) Limited (IIL) delivered a resilient performance in Q3 FY26 with 8% revenue growth, driven by volume expansion and B2B segment strength despite a challenging market. For the 9M FY26 period, revenue reached ₹1,714 crores, up 4% year-on-year, while PAT remained flattish at ₹128 crores due to increased finance and depreciation costs. The company is aggressively pursuing premiumization, with premium products now contributing 59% of the B2C portfolio. Management expects Q4 to remain under margin pressure but maintains a medium-term sustainable growth target of 8-10%.
Key Highlights
9M FY26 revenue increased to ₹1,714 crores from ₹1,641 crores, a growth of 4% YoY.
Gross profit for the 9-month period improved by 7% to ₹546 crores, though Q4 margins are expected to face pressure.
Premium products now account for 59% of the B2C segment, reflecting a strategic shift away from generics.
Launched 5 new products in 9M FY26, including SPARCLE and Altair, with 5 more planned for the upcoming Kharif season.
New manufacturing capacities at Dahej and Sotanala are on track to be operational by the end of FY26 and next Kharif respectively.
💼 Action for Investors
Investors should focus on the company's transition toward high-margin premium products and the timely commissioning of the Dahej plant. While near-term margin headwinds persist, the growing share of 'Maharatna' brands and new global collaborations provide a positive medium-term outlook.
Insecticides (India) Q3 Revenue Up 8% to ₹385 Cr; PAT Drops 40% on Margin Pressure
Insecticides (India) Limited reported a mixed Q3 FY26, with revenue growing 8% YoY to ₹385 crore, driven primarily by the B2B segment. However, Profit After Tax (PAT) saw a sharp decline of 40% YoY to ₹10 crore, impacted by higher finance costs, depreciation, and a shift in product mix. For the nine-month period (9M FY26), revenue grew 4% to ₹1,714 crore, while PAT remained flat at ₹128 crore. Management attributed the margin compression to industry-wide headwinds and erratic rainfall affecting the high-margin B2C segment.
Key Highlights
Q3 Revenue from operations increased by 8% YoY to ₹385 crore.
Profit After Tax (PAT) for Q3 fell significantly by 40% YoY to ₹10 crore.
EBITDA margins contracted to 7.1% in Q3 FY26 from 8.6% in the previous year.
Gross profit margins moderated to 32.4% due to a higher B2B sales mix and industry pressures.
Launched 5 new products during 9M FY26, including Sparcle and Torry Super, to drive future growth.
💼 Action for Investors
Investors should be cautious due to the significant decline in quarterly profitability and margin contraction. Monitor the company's ability to pass on costs and shift the mix back toward high-margin B2C products in upcoming quarters.
Insecticides (India) Declares ₹2 Interim Dividend; Q3 Consolidated PAT Drops 39% YoY
Insecticides (India) Limited has declared an interim dividend of ₹2 per share (20% of face value) for FY 2025-26, with the record date set for February 6, 2026. While consolidated revenue for Q3 FY26 grew by 7.6% YoY to ₹38,491.62 Lacs, the consolidated net profit saw a sharp decline of 39.2% to ₹1,053.82 Lacs. The bottom line was primarily pressured by a significant spike in finance costs, which rose from ₹140.61 Lacs to ₹468.18 Lacs YoY. Additionally, the company confirmed the successful dissolution of its Dubai-based subsidiary, IIL Overseas DMCC.
Key Highlights
Declared an interim dividend of ₹2.00 per equity share (20% of FV ₹10) with a record date of Feb 6, 2026.
Consolidated Revenue from Operations increased 7.6% YoY to ₹38,491.62 Lacs in Q3 FY26.
Consolidated Net Profit fell 39.2% YoY to ₹1,053.82 Lacs compared to ₹1,733.30 Lacs in the previous year.
Finance costs surged by 233% YoY to ₹468.18 Lacs, impacting overall profitability.
Basic and Diluted EPS for the quarter dropped to ₹3.60 from ₹5.96 in the year-ago period.
💼 Action for Investors
While the dividend provides a small immediate return, investors should be cautious of the sharp decline in net profit and rising interest expenses. Monitor the company's margin recovery and debt levels in the coming quarters before increasing exposure.
Insecticides (India) Promoters Transfer 67.65% Stake to Family Trusts for Succession Planning
The promoter group of Insecticides (India) Limited has completed an internal reorganization, transferring 1,96,83,052 equity shares, representing 67.65% of the company's share capital, to four family trusts. This transfer was executed as a gift at nil value for the purpose of succession planning and streamlining family assets. The transaction was conducted following a specific exemption granted by SEBI in December 2025, ensuring no open offer was triggered. Since this is an internal reshuffle within the promoter group, the total promoter shareholding remains unchanged.
Key Highlights
Transfer of 1,96,83,052 equity shares (67.65% stake) to family-controlled trusts.
Sanskriti Family Trust emerged as the largest holder among the trusts with a 64.66% stake.
Transaction executed as an off-market gift with zero monetary consideration.
Exemption granted by SEBI under Regulation 11(5) of SAST Regulations to facilitate the transfer.
Move is aimed at long-term succession planning and internal reorganization of promoter assets.
💼 Action for Investors
This is a routine internal restructuring for succession planning and does not change the company's fundamentals or management control. Investors should treat this as a neutral event.
Insecticides (India) Board to Meet Jan 30 for Q3 Results and Interim Dividend; Record Date Feb 6
Insecticides (India) Limited has scheduled a board meeting on January 30, 2026, to approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The board will also consider the declaration of an interim dividend for the financial year 2025-26. If a dividend is declared, the company has pre-emptively fixed February 6, 2026, as the record date for determining shareholder eligibility. Additionally, the trading window for insiders has been closed since January 1, 2026, and will remain so until 48 hours after the results are announced.
Key Highlights
Board meeting scheduled for January 30, 2026, to consider Q3 and 9M FY26 financial results.
Proposal for an interim dividend for FY 2025-26 to be discussed during the meeting.
Record date for the potential interim dividend is fixed as February 6, 2026.
Trading window for insiders remains closed from January 1, 2026, until 48 hours post-result declaration.
💼 Action for Investors
Investors should watch for the Q3 earnings performance and the quantum of the interim dividend on January 30. Those looking to qualify for the dividend should ensure they hold the stock before the February 6 record date.
Insecticides (India) Board to Meet Jan 30 for Q3 Results and Interim Dividend
Insecticides (India) Limited has scheduled a board meeting on January 30, 2026, to approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. In addition to the earnings report, the board will consider the declaration of an interim dividend for the financial year 2025-26. If a dividend is declared, the company has already fixed February 6, 2026, as the record date for determining shareholder eligibility. The trading window for insiders has been closed since January 1, 2026, and will remain so until 48 hours after the results are announced.
Key Highlights
Board meeting scheduled for January 30, 2026, to discuss Q3 and 9M FY26 results.
Proposal for interim dividend for FY 2026 to be considered during the same meeting.
Record date for the potential interim dividend is set for February 6, 2026.
Trading window for insiders remains closed from January 1, 2026, until 48 hours post-announcement.
💼 Action for Investors
Investors should track the Q3 earnings performance and the dividend payout ratio on January 30 to assess the company's cash flow health. Those interested in the dividend must ensure they hold shares before the ex-dividend date preceding February 6.
Insecticides (India) Promoters to Transfer 67.65% Stake to Family Trusts for Succession Planning
The promoter group of Insecticides (India) Limited is executing an internal reorganization to transfer a total of 67.65% stake to four family trusts. SEBI has granted a specific exemption from open offer requirements as the transaction is a non-commercial gift intended for succession planning. The Sanskriti Family Trust will emerge as the primary holding entity with a 64.66% stake. Total promoter group holding will remain unchanged at 72.30% following the completion of these transfers on or after January 05, 2026.
Key Highlights
Transfer of 1,96,83,052 shares representing 67.65% of the company's share capital to four family trusts.
Sanskriti Family Trust to acquire the largest portion of 1,88,14,302 shares (64.66% stake).
Transaction is conducted as a gift without monetary consideration for internal family reorganization.
SEBI granted exemption from Regulation 3(1) and 4 of SAST Regulations via order dated December 02, 2025.
Total promoter and promoter group shareholding remains constant at 72.30%.
💼 Action for Investors
This is a structural internal reorganization for succession planning and does not impact the company's fundamentals or operations. Investors should treat this as a neutral administrative event with no change in overall promoter control.